187 related articles for article (PubMed ID: 32504703)
1. Elevated plasma levels of asymmetric dimethylarginine and the risk for arrhythmic death in ischemic and non-ischemic, dilated cardiomyopathy - A prospective, controlled long-term study.
Burger AL; Stojkovic S; Diedrich A; Demyanets S; Wojta J; Pezawas T
Clin Biochem; 2020 Sep; 83():37-42. PubMed ID: 32504703
[TBL] [Abstract][Full Text] [Related]
2. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2.
Stojkovic S; Kaider A; Koller L; Brekalo M; Wojta J; Diedrich A; Demyanets S; Pezawas T
J Cell Mol Med; 2018 Apr; 22(4):2422-2429. PubMed ID: 29397580
[TBL] [Abstract][Full Text] [Related]
3. The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.
Anderssohn M; Rosenberg M; Schwedhelm E; Zugck C; Lutz M; Lüneburg N; Frey N; Böger RH
J Card Fail; 2012 Dec; 18(12):904-11. PubMed ID: 23207078
[TBL] [Abstract][Full Text] [Related]
4. Importance of Diastolic Function for the Prediction of Arrhythmic Death: A Prospective, Observer-Blinded, Long-Term Study.
Pezawas T; Burger AL; Binder T; Diedrich A
Circ Arrhythm Electrophysiol; 2020 Feb; 13(2):e007757. PubMed ID: 31944144
[TBL] [Abstract][Full Text] [Related]
5. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
[TBL] [Abstract][Full Text] [Related]
7. Cardiac biomarkers for risk stratification of arrhythmic death in patients with heart failure and reduced ejection fraction.
Burger AL; Stojkovic S; Diedrich A; Wojta J; Demyanets S; Pezawas T
Br J Biomed Sci; 2021 Oct; 78(4):195-200. PubMed ID: 33502288
[No Abstract] [Full Text] [Related]
8. Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction.
Lehmann HI; Goette A; Martens-Lobenhoffer J; Hammwöhner M; Röhl FW; Bukowska A; Ghanem A; Klein HU; Bode-Böger SM
Europace; 2011 Oct; 13(10):1428-35. PubMed ID: 21752828
[TBL] [Abstract][Full Text] [Related]
9. Risk of arrhythmic death in ischemic heart disease: a prospective, controlled, observer-blind risk stratification over 10 years.
Pezawas T; Diedrich A; Robertson D; Winker R; Richter B; Wang L; Schmidinger H
Eur J Clin Invest; 2017 Mar; 47(3):231-240. PubMed ID: 28102901
[TBL] [Abstract][Full Text] [Related]
10. Mitral annuloplasty in patients with ischemic versus dilated cardiomyopathy.
Szalay ZA; Civelek A; Hohe S; Brunner-LaRocca HP; Klövekorn WP; Knez I; Vogt PR; Bauer EP
Eur J Cardiothorac Surg; 2003 Apr; 23(4):567-72. PubMed ID: 12694777
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure.
Hsu CP; Lin SJ; Chung MY; Lu TM
Atherosclerosis; 2012 Dec; 225(2):504-10. PubMed ID: 23092827
[TBL] [Abstract][Full Text] [Related]
12. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
Briongos-Figuero S; Estévez A; Luisa Pérez M; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R
Int J Cardiol; 2019 Jan; 274():163-169. PubMed ID: 30206014
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
[TBL] [Abstract][Full Text] [Related]
14. Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction.
Merlo M; Gentile P; Artico J; Cannatà A; Paldino A; De Angelis G; Barbati G; Alonge M; Gigli M; Pinamonti B; Ramani F; Zecchin M; Pirozzi F; Stolfo D; Sinagra G
J Cardiovasc Med (Hagerstown); 2019 May; 20(5):343-350. PubMed ID: 30921270
[TBL] [Abstract][Full Text] [Related]
15. Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls.
Pezawas T; Diedrich A; Winker R; Robertson D; Richter B; Wang L; Byrne DW; Schmidinger H
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1101-8. PubMed ID: 25262115
[TBL] [Abstract][Full Text] [Related]
16. Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.
Streitner F; Herrmann T; Kuschyk J; Lang S; Doesch C; Papavassiliu T; Streitner I; Veltmann C; Haghi D; Borggrefe M
PLoS One; 2013; 8(5):e63911. PubMed ID: 23675514
[TBL] [Abstract][Full Text] [Related]
17. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
[TBL] [Abstract][Full Text] [Related]
18. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis.
Di Marco A; Anguera I; Schmitt M; Klem I; Neilan TG; White JA; Sramko M; Masci PG; Barison A; Mckenna P; Mordi I; Haugaa KH; Leyva F; Rodriguez Capitán J; Satoh H; Nabeta T; Dallaglio PD; Campbell NG; Sabaté X; Cequier Á
JACC Heart Fail; 2017 Jan; 5(1):28-38. PubMed ID: 28017348
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
[TBL] [Abstract][Full Text] [Related]
20. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
